Libby Topp

4.0k total citations
72 papers, 3.0k citations indexed

About

Libby Topp is a scholar working on Epidemiology, Toxicology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Libby Topp has authored 72 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 21 papers in Toxicology and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Libby Topp's work include HIV, Drug Use, Sexual Risk (35 papers), Substance Abuse Treatment and Outcomes (26 papers) and Opioid Use Disorder Treatment (21 papers). Libby Topp is often cited by papers focused on HIV, Drug Use, Sexual Risk (35 papers), Substance Abuse Treatment and Outcomes (26 papers) and Opioid Use Disorder Treatment (21 papers). Libby Topp collaborates with scholars based in Australia, Austria and United States. Libby Topp's co-authors include Louisa Degenhardt, Lisa Maher, Carolyn Day, Shane Darke, Richard P. Mattick, Jenny Iversen, Julie Hando, Handan Wand, Bridget M. Barker and Paul Dillon and has published in prestigious journals such as American Journal of Public Health, Addiction and AIDS.

In The Last Decade

Libby Topp

70 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libby Topp Australia 32 2.0k 885 807 574 548 72 3.0k
Kanna Hayashi Canada 32 3.0k 1.5× 478 0.5× 2.2k 2.8× 475 0.8× 391 0.7× 275 4.1k
Dan Werb Canada 26 1.7k 0.9× 349 0.4× 1.3k 1.6× 407 0.7× 279 0.5× 126 2.6k
David C. Marsh Canada 38 3.0k 1.5× 337 0.4× 3.2k 4.0× 689 1.2× 340 0.6× 176 5.0k
Stephen E. Lankenau United States 30 1.3k 0.7× 240 0.3× 1.1k 1.3× 503 0.9× 438 0.8× 100 2.5k
Samantha Colledge‐Frisby Australia 20 2.2k 1.1× 131 0.1× 823 1.0× 236 0.4× 275 0.5× 46 3.1k
Craig Fry Australia 26 1.1k 0.6× 254 0.3× 984 1.2× 185 0.3× 223 0.4× 86 2.2k
Carolyn Day Australia 32 2.0k 1.0× 196 0.2× 1.0k 1.3× 136 0.2× 171 0.3× 144 2.9k
Rüssel S. Falck United States 33 1.9k 1.0× 304 0.3× 816 1.0× 383 0.7× 411 0.8× 94 2.9k
Nadine Ezard Australia 20 723 0.4× 175 0.2× 394 0.5× 135 0.2× 441 0.8× 93 1.7k
Kamyar Arasteh United States 28 2.0k 1.0× 100 0.1× 602 0.7× 208 0.4× 140 0.3× 94 2.6k

Countries citing papers authored by Libby Topp

Since Specialization
Citations

This map shows the geographic impact of Libby Topp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libby Topp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libby Topp more than expected).

Fields of papers citing papers by Libby Topp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libby Topp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libby Topp. The network helps show where Libby Topp may publish in the future.

Co-authorship network of co-authors of Libby Topp

This figure shows the co-authorship network connecting the top 25 collaborators of Libby Topp. A scholar is included among the top collaborators of Libby Topp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libby Topp. Libby Topp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Islam, M. Mofizul, Libby Topp, Jenny Iversen, et al.. (2013). Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs. Australian and New Zealand Journal of Public Health. 37(2). 148–154. 28 indexed citations
2.
Topp, Libby, Carolyn Day, Handan Wand, et al.. (2013). A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Preventive Medicine. 57(4). 297–303. 50 indexed citations
3.
Islam, M. Mofizul, et al.. (2012). Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. International Journal of Drug Policy. 24(4). 326–332. 12 indexed citations
4.
Topp, Libby, Jenny Iversen, Eileen Baldry, & Lisa Maher. (2012). Housing Instability among People Who Inject Drugs: Results from the Australian Needle and Syringe Program Survey. Journal of Urban Health. 90(4). 699–716. 53 indexed citations
5.
Islam, M. Mofizul, Carolyn Day, Katherine M. Conigrave, & Libby Topp. (2012). Self-perceived problem with alcohol use among opioid substitution treatment clients. Addictive Behaviors. 38(4). 2018–2021. 11 indexed citations
6.
Topp, Libby. (2011). Locking Up Lives. 9(1). 10. 1 indexed citations
7.
Ward, James, Libby Topp, Jenny Iversen, et al.. (2011). Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs. Australian and New Zealand Journal of Public Health. 35(5). 421–426. 16 indexed citations
8.
Islam, M. Mofizul, Libby Topp, Carolyn Day, Angela Dawson, & Katherine M. Conigrave. (2011). The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. International Journal of Drug Policy. 23(2). 94–102. 86 indexed citations
9.
Iversen, Jenny, Libby Topp, Handan Wand, & Lisa Maher. (2011). Individual-level syringe coverage among Needle and Syringe Program attendees in Australia. Drug and Alcohol Dependence. 122(3). 195–200. 36 indexed citations
10.
Bruno, Raimondo, Allison Matthews, Libby Topp, et al.. (2009). Can the Severity of Dependence Scale Be Usefully Applied to ‘Ecstasy’?. Neuropsychobiology. 60(3-4). 137–147. 37 indexed citations
11.
Topp, Libby, Jenny Iversen, Handan Wand, et al.. (2008). Representativeness of Injecting Drug Users Who Participate in HIV Surveillance. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(5). 632–638. 38 indexed citations
12.
Dwyer, Robyn, Libby Topp, Lisa Maher, et al.. (2008). Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug and Alcohol Dependence. 100(1-2). 9–16. 75 indexed citations
13.
Topp, Libby. (2006). Medical cannabis lost in politics. 4(1). 12.
14.
Topp, Libby. (2006). Pharmacuetical diversion : Accidental harm reduction?. 4(2). 6. 1 indexed citations
15.
Degenhardt, Louisa, Bridget M. Barker, & Libby Topp. (2004). Patterns of ecstasy use in Australia: findings from a national household survey. Addiction. 99(2). 187–195. 78 indexed citations
16.
Topp, Libby, Bridget M. Barker, & Louisa Degenhardt. (2003). The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence. 73(1). 33–40. 110 indexed citations
17.
Darke, Shane, Sharlene Kaye, & Libby Topp. (2002). Cocaine use in New South Wales, Australia, 1996–2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. Drug and Alcohol Dependence. 67(1). 81–88. 42 indexed citations
18.
Darke, Shane, Libby Topp, & Joanne Ross. (2002). The injection of methadone and benzodiazepines among Sydney injecting drug users 1996–2000: 5‐year monitoring of trends from the Illicit Drug Reporting System. Drug and Alcohol Review. 21(1). 27–32. 55 indexed citations
19.
Topp, Libby, Louisa Degenhardt, Sharlene Kaye, & Shane Darke. (2002). The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system. Drug and Alcohol Review. 21(4). 341–348. 80 indexed citations
20.
Topp, Libby & Shane Darke. (1997). The applicability of the dependence syndrome to amphetamine. Drug and Alcohol Dependence. 48(2). 113–118. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kanna Hayashi Breakdown of academic impact, for papers by Dan Werb Breakdown of academic impact, for papers by David C. Marsh Breakdown of academic impact, for papers by Stephen E. Lankenau Breakdown of academic impact, for papers by Samantha Colledge‐Frisby Breakdown of academic impact, for papers by Craig Fry Breakdown of academic impact, for papers by Carolyn Day Breakdown of academic impact, for papers by Rüssel S. Falck Breakdown of academic impact, for papers by Nadine Ezard Breakdown of academic impact, for papers by Kamyar Arasteh
Rankless by CCL
2026